StockData
INVO Fertility, Inc. logo

INVO Fertility, Inc. (IVF) stock

IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$2.69+0.19 (+7.60%)

Close on Nov 11, 2026Market cap $6.74MP/E –Yield –

INVO Fertility, Inc. reported revenue of $7.53M for the twelve months to Jun 30, 2026. Free cash flow was -$7.06M. At the latest close the market valued the company at $6.74M.

Revenue
$7.53M
TTM Q2 2026
Operating income
-$5.93M
TTM Q2 2026
Free cash flow
-$7.06M
FY2025
EPS, diluted
-$214.64
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$6.74M
P/E ratio
–
Price to sales
0.90
Price to book
0.41
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$7.53M
Net income
-$6.95M
EPS, diluted
-$214.64
Free cash flow
-$7.06M
Book value per share
$6.36
Diluted shares
3M

Trading

Next earnings
Nov 16, 2026 (estimated, before the open)
Previous close
$2.50
Open
$2.73
Day's range
$2.47 – $2.77
Volume
22,941
Average volume (20 days)
36,327
Beta (5 years)
1.64
52-week range
$0.53 – $98.00
RSI (14 days)
53.7
Volatility (1 year)
1885.4%
Relative volume
0.06×
WACC
12.8%

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodIVFS&P 500DifferenceIVF per yearS&P 500 per year
1 month+269.8%-2.4%+272.2 pts
3 months-34.7%-1.2%−33.6 pts
Year to date-28.5%+12.3%−40.8 pts
1 year-87.6%+12.4%−100.1 pts
3 years-100.0%+78.8%−178.8 pts-92.9%+21.4%
5 years-100.0%+75.2%−175.2 pts-90.7%+11.9%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$7.53M

Gross profit

–

Operating income

-$5.93M

Net income

-$6.95M

EPS, diluted

–

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases INVO Fertility filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About INVO Fertility

Surgical & Medical Instruments & Apparatus

The company is a healthcare and biotechnology enterprise that focuses on fertility services and therapeutics. Its core operational segments comprise fertility clinic services and therapeutics development. Through its clinic operations and product offerings, the organization provides reproductive healthcare treatments, fertility solutions, and related therapeutic innovations. It conducts operations and manages ventures linked to entities such as NAYA Therapeutics and fertility clinics, including the Wisconsin Fertility Institute. Its principal customers consist of individual fertility patients seeking reproductive care, clinical practitioners, and partner healthcare organizations requiring reproductive technologies and specialized therapeutic solutions.

Company profile, executives and history

INVO Fertility stock: common questions

What is INVO Fertility's stock price?

IVF closed at $2.69 on Nov 11, 2026, up 7.60% on the day. Over the past 52 weeks it traded between $0.53 and $98.00.

What is INVO Fertility's market cap?

INVO Fertility was worth $6.74M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is IVF's P/E ratio?

INVO Fertility lost money over fiscal 2025 (diluted EPS -$214.64), so it has no meaningful P/E ratio.

How much revenue does INVO Fertility make?

INVO Fertility reported revenue of $7.53M for the twelve months to Jun 30, 2026.

Does INVO Fertility pay a dividend?

No. INVO Fertility has not paid a cash dividend over the last twelve months.

When does INVO Fertility report earnings next?

INVO Fertility is expected to report Q3 FY2026 results on Nov 16, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has IVF stock performed over the past year?

Including dividends, IVF returned -87.6% over the past year, against +12.4% for the S&P 500.

How many IVF shares are sold short?

0M shares were sold short at the latest FINRA report, 0.32% of the float, or 1.0 days of average trading volume.

Who are INVO Fertility's competitors?

Companies most similar to INVO Fertility by business, industry and size include FEMY, EBRCZ, WOK, MDNC, CNSY.

See a number that looks wrong?